Capital Options Slims for Cannabis Businesses, But Money Still Accessible
Cannabis companies looking for a cash injection will probably have a more challenging time in coming months than.
Cannabis companies looking for a cash injection will probably have a more challenging time in coming months than.
The psychedelics research company ended the quarter with less than $100K cash.
Cash-strapped Mydecine Innovations Group (NEO: MYCO) (OTC: MYCOF) continued to refocus its operations through the third quarter ended Sept..
A U.S. district judge has dismissed Florida Agriculture Commissioner Nikki Fried’s lawsuit challenging the federal laws that govern medical cannabis and firearms.
Judge Allen Winsor granted the Department of Justice’s (DOJ).
The modern marijuana industry is headed toward massive consolidation that will eventually feature just a handful of companies atop a global supply chain, predicted Curaleaf Executive Chairman Boris Jordan during an appearance.
High Times and the company it bought Moxie Holdings, have much in common. Both companies failed to go public as.
LSD is back with a flurry of new applications to treat various conditions.
By now, everybody in the psychedelics industry knows the story of lysergic acid diethylamide (LSD):
The safety profile of CBD is usually favourable. This organic chemical compound has fewer possible negative effects than pharmaceutical medications, which can lead to dependence and undesirable outcomes. Customers must comprehend.
At least seven localities in Colorado and Rhode Island voted down recreational marijuana sales measures on Election Day this week, another.
CBD is not only popular but also a holistic choice for people struggling with pain, inflammation, and sleep problems. But many first-time users wonder why CBD is so expensive. Some people.
We just saw the headlines, and maybe you saw it too: “California Fully Legalizes Medical Cannabis for Pets!” Please excuse the incredibly clickbait title here. Pets cannot consume your traditional medical.